Unknown

Dataset Information

0

Radio Electric Asymmetric Conveyer (REAC) technology to obviate loss of T cell responsiveness under simulated microgravity.


ABSTRACT: Alterations of the gravitational environment are likely to modify cell behavior. Several studies have proven that T cells are sensitive to gravity alterations and that microgravity conditions may induce immunosuppression and weakened T cell immune response in humans during spaceflights. The aim of this work was to elucidate if a specific treatment of Radio Electric Asymmetric Conveyer (REAC) technology could restore, after mitogenic activation (Con A), a correct expression of cytokine IL2 gene and its receptor IL2R alpha, which are inhibited in T cells under microgravity conditions, as demonstrated in several studies. The results of this study, conducted in microgravity simulated with Random Positioning Machine (RPM), confirm the T cell activation recovery and offer the evidence that REAC technology could contribute to the understanding of T cell growth responsiveness in space, reducing the impact of weightlessness on the immune system experienced by humans in long duration space missions.

SUBMITTER: Rinaldi S 

PROVIDER: S-EPMC6034838 | biostudies-literature | 2018

REPOSITORIES: biostudies-literature

altmetric image

Publications

Radio Electric Asymmetric Conveyer (REAC) technology to obviate loss of T cell responsiveness under simulated microgravity.

Rinaldi Salvatore S   Meloni Maria Antonia MA   Galleri Grazia G   Maioli Margherita M   Pigliaru Gianfranco G   Cugia Giulia G   Santaniello Sara S   Castagna Alessandro A   Fontani Vania V  

PloS one 20180706 7


Alterations of the gravitational environment are likely to modify cell behavior. Several studies have proven that T cells are sensitive to gravity alterations and that microgravity conditions may induce immunosuppression and weakened T cell immune response in humans during spaceflights. The aim of this work was to elucidate if a specific treatment of Radio Electric Asymmetric Conveyer (REAC) technology could restore, after mitogenic activation (Con A), a correct expression of cytokine IL2 gene a  ...[more]

Similar Datasets

| S-EPMC3651164 | biostudies-literature
| S-EPMC9300855 | biostudies-literature
| S-EPMC7561153 | biostudies-literature
| S-EPMC8584780 | biostudies-literature
| S-EPMC7483581 | biostudies-literature
| S-EPMC6520402 | biostudies-literature
2020-12-22 | GSE145967 | GEO
| S-EPMC8231837 | biostudies-literature
| S-EPMC8282859 | biostudies-literature
| S-EPMC8298474 | biostudies-literature